Jim Rotolo

Sapience Therapeutics, Inc.

NIH Rank #25017
  • Early Career

NIH Funding · FY2024

Total Funding
$632.1K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#25,017
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $632.1K across 1 grant · National rank #25017.

Top grants by award amount

Jim Rotolo's NIH grant portfolio, ranked by award amount.

  • 5R44CA265503-03R44
    Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
    $632.1K
    award amount

Affiliation

Institutions that have administered grants for Jim Rotolo.

Affiliated with Sapience Therapeutics, Inc. (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Sapience Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding